Literature DB >> 3575100

Cell cycle regulated synthesis of an abundant transcript for human chromosomal protein HMG-17.

M Bustin, N Soares, D Landsman, T Srikantha, J M Collins.   

Abstract

The abundance and cell cycle dependent expression of the mRNA for human nonhistone protein HMG-17 were studied in synchronized HeLa cells. Slot blot analysis indicates that the HMG-17 mRNA is a very abundant message, significantly more so than histone or actin mRNA. RNA prepared from tissue culture cells contains higher amounts of HMG-17 transcripts than RNA prepared from liver suggesting a correlation between the rate of cell division and HMG-17 mRNA levels. HMG-17 mRNA is present in the cells throughout the cell cycle however there is a significant increase in the mRNA levels late in S phase suggesting that the protein is deposited on chromatin after nucleosome assembly. Synthesis of the HMG-17 transcript is not coupled to DNA replication suggesting that the cell cycle related expression during late S phase is regulated in a different manner from that of the nucleosomal histones.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3575100      PMCID: PMC340748          DOI: 10.1093/nar/15.8.3549

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Chromosomal subunits in active genes have an altered conformation.

Authors:  H Weintraub; M Groudine
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

3.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

4.  mRNA of chromosomal proteins HMG-1 and HMG-2 are polyadenylated.

Authors:  M Bustin; N K Neihart; J B Fagan
Journal:  Biochem Biophys Res Commun       Date:  1981-08-14       Impact factor: 3.575

Review 5.  Active chromatin.

Authors:  S Weisbrod
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

6.  The interaction of high mobility proteins HMG14 and 17 with nucleosomes.

Authors:  G Sandeen; W I Wood; G Felsenfeld
Journal:  Nucleic Acids Res       Date:  1980-09-11       Impact factor: 16.971

7.  Nucleosome cores have two specific binding sites for nonhistone chromosomal proteins HMG 14 and HMG 17.

Authors:  J K Mardian; A E Paton; G J Bunick; D E Olins
Journal:  Science       Date:  1980-09-26       Impact factor: 47.728

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Synthesis of high mobility group proteins in regenerating rat liver.

Authors:  L Kuehl
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

10.  Organization of human histone genes.

Authors:  F Sierra; A Lichtler; F Marashi; R Rickles; T Van Dyke; S Clark; J Wells; G Stein; J Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

View more
  3 in total

1.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Replication-dependent and independent regulation of HMG expression during the cell cycle and conjugation in Tetrahymena.

Authors:  T Wang; C D Allis
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

3.  Deposition of chromosomal protein HMG-17 during replication affects the nucleosomal ladder and transcriptional potential of nascent chromatin.

Authors:  M P Crippa; L Trieschmann; P J Alfonso; A P Wolffe; M Bustin
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.